US life science funding unclear

Despite conference agreement, 2004 budgets for NIH and NSF face prolonged scrutiny

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Members of the two houses of the US Congress last week (November 25) reached agreement on a $328.1 billion omnibus spending measure that funds 11 departments and numerous agencies, including the National Institutes of Health (NIH) and the National Science Foundation (NSF). The bill, which includes modest, though respectable, increases to both agencies, faces a very uncertain future when the full House and possibly Senate convene briefly next week to consider it.

The fiscal year (FY) 2004 consolidated conference bill (HR 2673) gives NIH $27.98 billion, a 3.7% increase of $1.0 billion over last year's appropriation, and $318.6 million more than the White House had requested. House appropriators noted the real increase is more than 7% after excluding one-time expenses in the FY 2003 budget. The National Institute of Allergy and Infectious Diseases, the lead NIH institute for biodefense research, would receive $4.3 billion, a 17% increase over last year. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio